LGALS13 and preeclampsia: At this phase an exaggerated maternal systemic inflammatory response already dominates preeclampsia [11], [12], [57], [58], and maternal serum concentrations of PP13 and its bioavailability at the maternal-fetal interface may not have a similar effect on the development of preeclampsia compared to the first trimester.